Evaluation of the Safety and Efficacy of WST11-mediated Vascular Targeted Photodynamic Therapy in Non-resectable or Inoperable Cholangiocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2016
At a glance
- Drugs Padeliporfin (Primary)
- Indications Cholangiocarcinoma
- Focus Adverse reactions
- Sponsors Steba Biotech
- 04 Jan 2012 Planned end date changed from 1 Sep 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Mar 2011 Planned end date changed from 1 Dec 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.